
### [NCIT:C37193](http://purl.obolibrary.org/obo/NCIT_C37193)
**Label:** Anaplastic Large Cell Lymphoma, ALK-Positive

**Subclasses:** [NCIT:C37195](http://purl.obolibrary.org/obo/NCIT_C37195) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C129598](http://purl.obolibrary.org/obo/NCIT_C129598) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive), 

**Class expressions from DL-Learner:**

- Thing 55.13%
- [NCIT:C99873](http://purl.obolibrary.org/obo/NCIT_C99873) (CLTC/ALK Fusion Gene) 51.22%
- [NCIT:C99869](http://purl.obolibrary.org/obo/NCIT_C99869) (RNF213/ALK Fusion Gene) 51.22%
- [NCIT:C99361](http://purl.obolibrary.org/obo/NCIT_C99361) (NPM1/ALK Fusion Gene) 51.22%
- [NCIT:C38184](http://purl.obolibrary.org/obo/NCIT_C38184) (ALK Gene) 51.22%
- [NCIT:C101085](http://purl.obolibrary.org/obo/NCIT_C101085) (TPM4/ALK Fusion Gene) 51.22%
- [NCIT:C101083](http://purl.obolibrary.org/obo/NCIT_C101083) (TPM3/ALK Fusion Gene) 51.22%
- [NCIT:C101075](http://purl.obolibrary.org/obo/NCIT_C101075) (TFG/ALK Fusion Gene) 51.22%
- [NCIT:C101059](http://purl.obolibrary.org/obo/NCIT_C101059) (MSN/ALK Fusion Gene) 51.22%
- [NCIT:C101046](http://purl.obolibrary.org/obo/NCIT_C101046) (ATIC/ALK Fusion Gene) 51.22%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 36.57%


